Baselga, Jose et al
"Recombinant Humanized Anti-HER2 Antibody (Herceptin™) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts." Cancer Research
58.13
(1998):
2825-2831.
Web. 17 Oct. 2019.
